Bimodal concentration-response of nicotine involves the nicotinic acetylcholine receptor, transient receptor potential vanilloid type 1, and transient receptor potential ankyrin 1 channels in mouse trachea and sensory neurons

Journal of Pharmacology and Experimental Therapeutics

Volumn 347, Issue 2, 2013, Pages 529-539

  Kichko, Tatjana I ^a   Lennerz, Jochen ^b   Eberhardt, Mirjam ^a,d   Babes, Ramona M ^a,c   Neuhuber, Winfried ^a   Kobal, Gerd ^e   Reeh, Peter W ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF ULM   (Germany)

^c CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^d HANNOVER MEDICAL SCHOOL   (Germany)

^e Altria Client Services Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACROLEIN; ALPHA BUNGAROTOXIN; CALCITONIN GENE RELATED PEPTIDE; CALCIUM; CAMPHOR; EPIBATIDINE; HEXAMETHONIUM; MECAMYLAMINE; METHYLLYCACONITINE; N (4 ISOPROPYLPHENYL) 2 (1,2,3,6 TETRAHYDRO 1,3 DIMETHYL 2,6 DIOXO 7H PURIN 7 YL)ACETAMIDE; N (4 TERT BUTYLPHENYL) 4 (3 CHLORO 2 PYRIDINYL) 1 PIPERAZINECARBOXAMIDE; NICOTINE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; TRANSIENT RECEPTOR POTENTIAL CHANNEL A1; VANILLOID RECEPTOR; VANILLOID RECEPTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTINICOTINIC ACTIVITY; ARTICLE; BINDING SITE; CALCIUM TRANSPORT; CELL MEMBRANE PERMEABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG EFFICACY; DRUG POTENCY; FEMALE; MOUSE; NODOSE GANGLION; NONHUMAN; PH; PRIORITY JOURNAL; SENSORY NERVE CELL; SMOKING; SPINAL GANGLION; TRACHEA; VAGUS NERVE;

ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; CELL CULTURE TECHNIQUES; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GANGLIA, SENSORY; HYDROGEN-ION CONCENTRATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NICOTINE; RECEPTORS, NICOTINIC; SENSORY RECEPTOR CELLS; TRACHEA; TRANSIENT RECEPTOR POTENTIAL CHANNELS; TRPV CATION CHANNELS;

EID: 84886067025     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.113.205971     Document Type: Article

References (59)

1. Andrè E, Campi B, Materazzi S, Trevisani M, Amadesi S, Massi D, Creminon C, Vaksman N, Nassini R, and Civelli M, et al. (2008) Cigarette smoke-induced neurogenic inflammation is mediated by α,β-unsaturated aldehydes and the TRPA1 receptor in rodents. J Clin Invest 118:2574-2582.
2. Arias HR (1997) Topology of ligand binding sites on the nicotinic acetylcholine receptor. Brain Res Brain Res Rev 25:133-191.
3. Ashton H, Marsh VR, Millman J.E., Rawlins MD, Telford R, and Thompson JW (1980) Biphasic dose-related responses of the CNV (contingent negative variation) to I.V. nicotine in man. Br J Clin Pharmacol 10:579-589.
4. Benowitz NL, Hukkanen J, and Jacob P, 3rd (2009) Nicotine chemistry, metabolism, kinetics and biomarkers. Handbook Exp Pharmacol 192:29-60.
5. Bernardini N, Sauer SK, Haberberger R, Fischer M.J., and Reeh PW (2001) Excitatory nicotinic and desensitizing muscarinic (M2) effects on C-nociceptors in isolated rat skin. J Neurosci 21:3295-3302.
6. Bolliger CT, van Biljon X, and Axelsson A (2007) A nicotine mouth spray for smoking cessation: a pilot study of preference, safety and efficacy. Respiration 74:196-201.
7. Bradley D (1993) Frog venom cocktail yields a one-handed painkiller. Science 261: 1117.
8. Brain SD (1997) Sensory neuropeptides: their role in inflammation and wound healing. Immunopharmacology 37:133-152.
9. Clarke PB (1990) Dopaminergic mechanisms in the locomotor stimulant effects of nicotine. Biochem Pharmacol 40:1427-1432.
10. Davis JB, Gray J, Gunthorpe M.J., Hatcher JP, Davey PT, Overend P, Harries M.H., Latcham J., Clapham C, and Atkinson K, et al. (2000) Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature 405:183-187.
11. Dessirier JM, Chang HK, O'Mahony M, and Carstens E (2000) Cross-desensitization of capsaicin-evoked oral irritation by high but not low concentrations of nicotine in human subjects. Neurosci Lett 290:133-136.
12. Eid SR, Crown ED, Moore E.L., Liang HA, Choong KC, Dima S, Henze D.A., Kane SA, and Urban MO (2008) HC-030031, a TRPA1 selective antagonist, attenuates inflammatory- and neuropathy-induced mechanical hypersensitivity. Mol Pain 4:48-58.
13. Einarson TR and Einarson A (1997) Hiccups following nicotine gum use. Ann Pharmacother 31:1263-1264.
14. Everaerts W, Gees M, Alpizar Y.A., Farre R., Leten C, Apetrei A, Dewachter I., van LeuvenF, Vennekens R, and De Ridder D, et al. (2011) The capsaicin receptor TRPV1 is a crucial mediator of the noxious effects of mustard oil. Curr Biol 21:316-321.
15. Food and Drug Administration (FDA) (1982) New drugs: camphorated oil drug products for human use. Fed Regist 47:41716-41720.
16. Fucile S, Sucapane A, and Eusebi F (2005) Ca2+ permeability of nicotinic acetylcholine receptors from rat dorsal root ganglion neurones. J Physiol 565:219-228.
17. Fujita F, Uchida K, Moriyama T., Shima A, Shibasaki K, Inada H., Sokabe T, and Tominaga M (2008) Intracellular alkalization causes pain sensation through activation of TRPA1 in mice. J Clin Invest 118:4049-4057.
18. Haberberger RV, Bernardini N, Kress M., Hartmann P, Lips KS, and Kummer W (2004) Nicotinic acetylcholine receptor subtypes in nociceptive dorsal root ganglion neurons of the adult rat. Auton Neurosci 113:32-42.
19. Hauser-Kronberger C., Hacker GW, Franz P, Albegger K., and Dietze O (1997) CGRP and substance P in intraepithelial neuronal structures of the human upper respiratory system. Regul Pept 72:79-85.
20. Hummel T, Hummel C, Pauli E., and Kobal G (1992) Olfactory discrimination of nicotine-enantiomeres by smokers and non-smokers. Chem Senses 17:13-21. 10.1093/chemse/17.1.13.
21. Jiménez Ruiz CA, Cisneros C, Perelló Bosch O, Barruero Ferrero M, Hernández Mezquita MA, and Solano Reina S (2000) Individual treatment of smoking addiction. Results using 2 and 4 mg nicotine gum [article in Spanish]. Arch Bronconeumol 36:129-132.
22. Jinks SL and Carstens E (1999) Activation of spinal wide dynamic range neurons by intracutaneous microinjection of nicotine. J Neurophysiol 82:3046-3055.
23. Jung J, Hwang SW, Kwak J, Lee S.Y., Kang CJ, Kim WB, Kim D, and Oh U (1999) Capsaicin binds to the intracellular domain of the capsaicin-activated ion channel. J Neurosci 19:529-538.
24. 2+) permeation through the nociceptor cation channel TRPA1. Biophys J 98:773-783.
25. Kichko TI and Reeh PW (2009) TRPV1 controls acid- and heat-induced calcitonin gene-related peptide release and sensitization by bradykinin in the isolated mouse trachea. Eur J Neurosci 29:1896-1904.
26. Krebs SJ, Petros TV, and Beckwith BE (1994) Effects of smoking on memory for prose passages. Physiol Behav 56:723-727.
27. Kwan KY, Allchorne AJ, Vollrath M.A., Christensen AP, Zhang DS, Woolf CJ, and Corey DP (2006) TRPA1 contributes to cold, mechanical, and chemical nociception but is not essential for hair-cell transduction. Neuron 50:277-289.
28. Lee LY, Sant'Ambrogio FB, Mathew OP, and SantAmbrogio GJ (1987) Acute effect of cigarette smoke on laryngeal receptors. J Appl Physiol 62:1575-1581.
29. 24+ channels in rat pinealocytes. J Physiol 499:329-340.
30. Liu L and Simon SA (1996) Capsaicin and nicotine both activate a subset of rat trigeminal ganglion neurons. Am J Physiol 270:C1807-C1814.
31. Liu L, Zhu W, Zhang Z.S., Yang T., Grant A, Oxford G, and Simon SA (2004) Nicotine inhibits voltage-dependent sodium channels and sensitizes vanilloid receptors. J Neurophysiol 91:1482-1491.
32. Lu H, Chen X, and Zhan CG (2007) First-principles calculation of pKa for cocaine, nicotine, neurotransmitters, and anilines in aqueous solution. JPhys Chem B 111: 10599-10605.
33. Matta SG, Balfour DJ, Benowitz N.L., Boyd RT, Buccafusco JJ, Caggiula AR, Craig C.R., Collins AC, Damaj MI, and Donny EC, et al. (2007) Guidelines on nicotine dose selection for in vivo research. Psychopharmacology (Berl) 190:269-319.
34. McDonald DM, Mitchell RA, Gabella G, and Haskell A (1988) Neurogenic inflammation in the rat trachea. II. Identity and distribution of nerves mediating the increase in vascular permeability. J Neurocytol 17:605-628.
35. Moffatt JD, Cocks TM, and Page CP (2004) Role of the epithelium and acetylcholine in mediating the contraction to 5-hydroxytryptamine in the mouse isolated trachea. Br J Pharmacol 141:1159-1166.
36. Myers AC, Kajekar R, and Undem BJ (2002) Allergic inflammation-induced neuropeptide production in rapidly adapting afferent nerves in guinea pig airways. Am J Physiol Lung Cell Mol Physiol 282:L775-L781.
37. Nagy I, Reeh PW, Srubek Tomassy G, and Santha P Flor H, Kalso E, and Dostrovsky JO eds(2006) Control of activity: relationship between excitatory and inhibitory receptors expressed by nociceptors, in Proceedings of the 11th World Congress on Pain (Flor H, Kalso E, Dostrovsky JO eds) pp 109-118, IASP Press, Seattle.
38. Nakamura M, Haga T, Miyano M., Sasaki H, and Takishima TJ (1986) Dose-response curves of central and peripheral airways to nicotine injections in dogs. J Appl Physiol 61:1677-1685.
39. Park TJ, Seo HK, Kang B.J., and Kim KT (2001) Noncompetitive inhibition by camphor of nicotinic acetylcholine receptors. Biochem Pharmacol 61:787-793.
40. Perkins KA, DiMarco A, Grobe J.E., Scierka A., and Stiller RL (1994) Nicotine discrimination in male and female smokers. Psychopharmacology (Berl) 116:407-413.
41. Picciotto MR (2003) Nicotine as a modulator of behavior: beyond the inverted U. Trends Pharmacol Sci 24:493-499 Review.
42. Poenie M and Tsien R (1986) Fura-2: a powerful new tool for measuring and imaging [Ca2+]i in single cells. Prog Clin Biol Res 210:53-56.
43. Rau KK, Johnson RD, and Cooper BY (2005) Nicotinic AChR in subclassified capsaicin-sensitive and -insensitive nociceptors of the rat DRG. J Neurophysiol 93: 1358-1371.
44. Roemer E, Schorp MK, Piadé JJ, Seeman JI, Leyden DE, and Haussmann HJ (2012) Scientific assessment of the use of sugars as cigarette tobacco ingredients: a review of published and other publicly available studies. Crit Rev Toxicol 42:244-278.
45. Rowell PP and Li M (1997) Dose-response relationship for nicotine-induced up-regulation of rat brain nicotinic receptors. J Neurochem 68:1982-1989.
46. Ruparel NB, Patwardhan AM, Akopian A.N., and Hargreaves KM (2008) Homologous and heterologous desensitization of capsaicin and mustard oil responses utilize different cellular pathways in nociceptors. Pain 135:271-279.
47. Stanfill SB, Connolly GN, Zhang L, Jia L.T., Henningfield JE, Richter P, Lawler TS, Ayo-Yusuf OA, Ashley D.L., and Watson CH (2011) Global surveillance of oral tobacco products: total nicotine, unionised nicotine and tobacco-specific N-nitrosamines. Tob Control 20:e2.
48. Steen KH and Reeh PW (1993) Actions of cholinergic agonists and antagonists on sensory nerve endings in rat skin, in vitro. J Neurophysiol 70:397-405.
49. Stetzer E, Ebbinghaus U, Storch A., Poteur L, Schrattenholz A, Kramer G., Methfessel C, and Maelicke A (1996) Stable expression in HEK-293 cells of the rat α3/β4 subtype of neuronal nicotinic acetylcholine receptor. FEBS Lett 397:39-44.
50. Tanelian DL (1991) Cholinergic activation of a population of corneal afferent nerves. Exp Brain Res 86:414-420.
51. Talavera K, Gees M, Karashima Y., Meseguer VM, Vanoirbeek JA, Damann N, Everaerts W., Benoit M, Janssens A, and Vennekens R, et al. (2009) Nicotine activates the chemosensory cation channel TRPA1. Nat Neurosci 12:1293-1299.
52. Tomar SL and Henningfield JE (1997) Review of the evidence that pH is a determinant of nicotine dosage from oral use of smokeless tobacco. Tob Control 6: 219-225.
53. Tsirulnikov K, Abuladze N, Bragin A., Faull K, Cascio D, Damoiseaux R., Schibler MJ, and Pushkin A (2012) Inhibition of aminoacylase 3 protects rat brain cortex neuronal cells from the toxicity of 4-hydroxy-2-nonenal mercapturate and 4-hydroxy-2-nonenal. Toxicol Appl Pharmacol 263:303-314.
54. Valenzano KJ, Grant ER, Wu G, Hachicha M., Schmid L, Tafesse L, Sun Q., Rotshteyn Y, Francis J, and Limberis J, et al. (2003) N-(4-tertiarybutylphenyl)- 4-(3-chloropyridin-2-yl)tetrahydropyrazine-1(2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: I. in vitro characterization and pharmacokinetic properties. J Pharmacol Exp Ther 306:377-386.
55. Vriens J, Appendino G, and Nilius B (2009) Pharmacology of vanilloid transient receptor potential cation channels. Mol Pharmacol 75:1262-1279.
56. Wessler I and Kirkpatrick CJ (2008) Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans. Br J Pharmacol 154:1558-1571.
57. Xu H, Blair NT, and Clapham DE (2005) Camphor activates and strongly desensitizes the transient receptor potential vanilloid subtype 1 channel in a vanilloid-independent mechanism. J Neurosci 25:8924-8937.
58. Zia S, Ndoye A, Lee T.X., Webber RJ, and Grando SA (2000) Receptor-mediated inhibition of keratinocyte migration by nicotine involves modulations of calcium influx and intracellular concentration. J Pharmacol Exp Ther 293:973-981.
59. Zimmermann M (1983) Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16:109-110.